SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000930413-13-003355
Filing Date
2013-06-10
Accepted
2013-06-10 16:50:57
Documents
11
Period of Report
2013-04-30

Document Format Files

Seq Description Document Type Size
1 c74024_10q.htm 10-Q 640014
2 c74024_ex31-1.htm EX-31.1 9399
3 c74024_ex31-2.htm EX-31.2 9394
4 c74024_ex32-1.htm EX-32.1 3341
5 c74024_ex32-2.htm EX-32.2 3357
  Complete submission text file 0000930413-13-003355.txt   6289228

Data Files

Seq Description Document Type Size
6 enz-20130430.xml EX-101.INS 1300225
7 enz-20130430.xsd EX-101.SCH 45516
8 enz-20130430_cal.xml EX-101.CAL 36150
9 enz-20130430_def.xml EX-101.DEF 246968
10 enz-20130430_lab.xml EX-101.LAB 333784
11 enz-20130430_pre.xml EX-101.PRE 252266
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 001-09974 | Film No.: 13903965
SIC: 8071 Services-Medical Laboratories